This review highlights the pathophysiology, diagnosis, and management of pericardial diseases in patients with end-stage renal disease, addressing a gap in current guidelines.
Answers are grounded in this paper and cite their sources.
Rising ESRD prevalence increases pericardial syndromes needing intensive management; leaves open gaps in optimal therapies.
A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic pericarditis, the most common manifestation of uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis. Constrictive pericarditis is also well documented in this population, ultimately resulting in pericardiectomy for definitive treatment. The management of pericardial diseases in ESRD patients involves internists, cardiologists, and nephrologists. Current guidelines lack clarity with respect to the management of pericardial processes in the ESRD population. Our review aims to describe the etiology, classification, clinical manifestations, diagnostic imaging tools, and treatment options of pericardial diseases in this population.
No takes yet. Share an insight, caveat, or question.
Rehman et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: